Rosiglitazone and Stroke - a phase IV clinical study of FDA data
Summary:
Stroke is reported as a side effect among people who take Rosiglitazone (rosiglitazone maleate), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Avandia, and have Diabetes.
The phase IV clinical study analyzes which people have Stroke when taking Rosiglitazone. It is created by eHealthMe based on reports of 4,694 people who have side effects when taking Rosiglitazone from the FDA, and is updated regularly.
What is Rosiglitazone?
Rosiglitazone has active ingredients of rosiglitazone maleate. eHealthMe is studying from 4,700 Rosiglitazone users. Check the latest studies of Rosiglitazone.
What is Stroke?
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,311 drugs and 3,035 conditions by eHealthMe. Check the latest studies of Stroke.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
4,694 people reported to have side effects when taking Rosiglitazone.
Among them, 549 people (11.7%) have Stroke.

Among these 549 people:
How long have people been on Rosiglitazone when they have Stroke? *
What is the gender of people who have Stroke when taking Rosiglitazone? *
What is the age of people who have Stroke when taking Rosiglitazone? *
What are other drugs people take besides Rosiglitazone? *
What are other side effects people have besides Stroke? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Rosiglitazone and have Stroke?
- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Rosiglitazone:
- Rosiglitazone (4,700 reports)
Stroke treatments and more:
- Stroke (334,635 reports)
How severe was Stroke and when was it recovered:
Expand to all the drugs that have ingredients of rosiglitazone maleate:
- Stroke and drugs with ingredients of rosiglitazone maleate (22,997 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rosiglitazone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Stroke:
- Stroke (2,311 drugs)
Browse all the conditions that are associated with Stroke:
- Stroke (3,035 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on rosiglitazone maleate (the active ingredients of Rosiglitazone) and Rosiglitazone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Clonazepam and Bioflavonoids - 2 seconds ago
- Doxycycline and Lactulose drug interactions for men aged 50-59 - 5 seconds ago
- Mevacor and Losartan drug interactions for men aged 60+ - 7 seconds ago
- Could Revlimid cause Spinal Fracture? - 10 seconds ago
- Drug interactions of Olanzapine and Aspirin - 25 seconds ago
- Could Rifampin cause Cholecystitis? - 34 seconds ago
- Temaz and Blood Creatine Phosphokinase Increased for Men aged 20-29 - 35 seconds ago
- Botox vs. Effexor, side effect and effectiveness comparison - 35 seconds ago
- Could Xolair cause Temperature Intolerance? - 37 seconds ago
- Colitis Ischaemic and drugs of ingredients of potassium - 38 seconds ago